has perhaps been best studied in the developing cortex (Lillien, 1998; Shen et al., 1998 
cell survival at 3 and 5 days following infection. Doublevolved in this pathway is Rsk, which is activated by MEK/ERK and which directly phosphorylates mouse label analysis for the viral gene product and TUNEL ( Figure 2D ) revealed that A-C/EBP expression had no C/EBP␤ on Thr217 (Buck et al., 1999). To determine whether Rsk might be one way that MEK "talks to" the effect on survival relative to controls. Moreover, approximately the same number of cells were A-C/EBP positive C/EBPs, we performed Western blots for phosphorylated Rsk1. This analysis revealed that progenitors exat 3 and 6 days postinfection (approximately 20%), indicating that A-C/EBP expressing cells did not die during pressed Rsk1 and that it was activated by FGF2 ( Figure  3F ). To test the hypothesis that MEK might promote this time period. Finally, Hoechst staining of similar cultures at 6 days postinfection demonstrated that approxineurogenesis via an Rsk1-C/EBP pathway, we then utilized a C/EBP␤ mutant in which Thr217 was replaced mately 8% and 11% of GFP-versus A-C/EBP-infected cells displayed the fragmented nuclear morphology typiby glutamate (Glu-217), thereby acting as a phosphorylation mimic at the Rsk site. cal of apoptosis, a difference that was not statistically significant (p ϭ 0.171, results from four experiments).
For these experiments, we first showed that progenitors were reliably cotransfected using independent plasThus, inhibition of the C/EBPs had no effect on cell survival at any time point during these experiments. mids expressing GFP and red fluorescent protein (RFP) (data not shown). We then cotransfected progenitor We next asked whether C/EBPs were essential for progenitors to transcribe the neuronal T␣1 ␣-tubulin procells shortly after plating with the C/EBP␤ Glu-217 mutant and GFP, or, as controls, with wild-type C/EBP␤ moter. Double-label immunocytochemistry of cells infected for 3 days with A-C/EBP or GFP adenoviruses and GFP or GFP alone. Two days later, we performed immunocytochemistry for NSE, NeuN, or ␤III-tubulin. . We first ensured that we could transfect cycling progenitors; the rodent promoter, is neuron-specific and reinduced during neuronal regeneration (Hieber et al., 1998). This immunocytochemical analysis for Ki67, a protein expressed in dividing cells, revealed that approximately comparison revealed three sequence motifs of 6-11 nucleotides that were almost identical in sequence in the 70% of cells transfected with a GFP expression construct were actively dividing ( Figure 3D ). We then transtwo promoters, and that were in similar locations within the first Ϫ200 nucleotides ( Figure 4A ). Two of these fected progenitors with DN-C/EBP; double-label analysis at 3 days showed that DN-C/EBP significantly motifs, those located at Ϫ71 and Ϫ120, are at the core of putative C/EBP family binding sites ( Figure 4A ). inhibited the induction of NSE relative to GFP-transfected cells ( Figure 3E) . Thus, C/EBP transcriptional acTo ask whether these conserved elements were functional C/EBP sites, we performed heterologous cotranstivity is essential for induction of neuronal gene expression as progenitors become neurons. fection experiments. Initially, we utilized a minimal 176 nucleotide T␣1 ␣-tubulin promoter that contains all three conserved sites ( Figure 4A ) and that is sufficient to target Phosphorylation of C/EBP on the Rsk Site neuronal gene expression in transgenic mice (P.H., A.S.,
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A.P., and F.D.M., unpublished data). Expression plasActivation of MEK leads to phosphorylation of C/EBPs mids encoding C/EBP ␣, ␤, or ␦ were cotransfected and enhanced transcriptional activity. One kinase in- Figure 4D ). The magni-ACCGATCACCA, and site C from GGGTCTGGACCAA tude of this increase was similar for both promoter con-CAG to GGGGTCTGGAGGGGCAGGAAAAG. Initially, as structs but was lower than with the CAT assays, potena control, we made oligonucleotides containing the tially due to differences in stability of the two reporter same mutations, and performed gel shift assays. These proteins. Deletion of the sequences from Ϫ110 to Ϫ176 experiments revealed that the C/EBP binding comresulted in a consistent decrease in C/EBP-mediated plexes formed with the oligonucleotides for sites A, B, trans-activation from 10-to 3-fold ( Figure 4D) . Further or C could not be competed out with the mutated oligodeletion of the promoter to Ϫ85 had no further effect, nucleotides for those same sites ( Figure 6A ). We then indicating (i) that site(s) essential for C/EBP trans-activagenerated the same mutations within the context of the tion are located between Ϫ176 and Ϫ110, and down-T␣1 minimal promoter driving the CAT reporter gene, stream of Ϫ85 (Figure 4A) , and (ii) that the conserved and performed CAT assays on NIH 3T3 cells heterolomotif between Ϫ85 and Ϫ110 is not important for C/EBP gously cotransfected with C/EBP␤ plus the mutated vertrans-activation.
sus wild-type minimal promoter ( Figure 6B ). All data To further confirm that the conserved sequence elewere normalized to a cotransfected CMV-lacZ conments were C/EBP binding sites, we performed gel shift struct. These assays revealed that, while the mutations assays. Oligonucleotides were generated to a consenhad little or no effect on the basal level of transcription sus C/EBP site (Williams et al., 1995) , as well as to sites from the minimal promoter, the robust C/EBP-mediated A, B, and C in the minimal promoter ( Figure 4A) , and transcription was greatly decreased ( Figure 6B ). Thus, were used in gel shifts with liver nuclear extracts, a these three sites are in fact bona fide C/EBP binding rich, well-characterized source of C/EBP activity. The sites, and they are essential for the robust, C/EBP-mediconsensus C/EBP oligonucleotide formed one major ated transcriptional activation of the T␣1 promoter. complex when incubated with liver nuclear extract (Figure 5A) . A complex of similar size was observed with Inhibition of C/EBPs Enhances CNTF-Mediated extracts from cortical progenitor cells (Figure 5B) , from Gliogenesis embryonic brain (Figure 5E ), or from cortical cells isoTogether, these data support the hypothesis that MEK lated from the telencephalon at time points ranging from activation leads to Rsk-mediated phosphorylation of E12 to E18 (data not shown), consistent with the expres-C/EBPs, and that C/EBPs then promote neurogenesis sion of C/EBPs in developing cortical progenitors and from cortical progenitor cells by directly trans-activating neurons (Figure 2 ). This complex formation was inhibited neuronal genes such as T␣1 ␣-tubulin. To determine the by competition with a 125-fold excess of cold consensus fate of cortical progenitors expressing A-C/EBP, we first oligonucleotide, as well as by a similar excess of oligonucleotides corresponding to sites A, B, or C from the asked whether they were subverted to an astrocytic We then asked whether inhibition of C/EBP affected the gliogenesis that occurs when CNTF is added to the cultures in the presence of FGF2. Progenitors were infected with A-C/EBP, ␤-galactosidase, or GFP adenoviruses and then exposed to FGF2 plus 50 ng/ml CNTF. Immunostaining 5 days later revealed that while 10%-30% of control, GFP-or ␤-galactosidase-expressing cells coexpressed GFAP, 70%-90% of the A-C/EBPpositive cells expressed this glial marker ( Figure 7C) . Thus, inhibition of C/EBP activity biases cortical progenitor cells to become astrocytes in response to CNTF, suggesting that C/EBP transcriptional activity not only promotes neurogenesis, but also actively inhibits gliogenesis in cortical progenitor cells.
Discussion

Data presented here support four major conclusions.
First, these studies demonstrate that the activities of both MEK and the C/EBP family are necessary for cortical progenitors to become neurons in the presence of FGF2 and/or PDGF. Second, our data with the C/EBP␤ Rsk-site phosphorylation mimic suggests that a MEKRsk pathway directly promotes the generation of neurons from cortical progenitors via phosphorylation of C/EBPs. Third, experiments with the T␣1 ␣-tubulin promoter indicate that the C/EBPs promote the progenitor-to-neuron transition by direct transcription of neuron-specific genes. Finally, our studies examining glial differentiation suggest that activated C/EBPs not only promote neurogenesis, but also inhibit growth-factormediated gliogenesis. Together, these data support a model where growth factors that enhance the generation of neurons do so via activation of a MEK-Rsk-C/EBP signaling cascade that leads directly to transcription of early, neuron-specific genes, while at the same time Together, these studies identify a novel growth factor-
